About
Transforming cancer care by expanding the molecular target space
Our Mission
Our mission is to improve patient care by unleashing the full potential of targeted cancer therapies using our transformative cell surfaceome discovery technology.
About Us
At DISCO we are able to unlock the entire cancer cell surface at scale by identifying surface-bound proteins and uncovering protein communities. This approach thus permits unravelling comprehensive target information that neither standard proteomics, nor genome or transcriptome sequencing can provide.
Unique team with surfaceome and oncology expertise
We have formed a stellar team of individuals with diverse backgrounds from academia, biotech and pharma and covering all relevant areas of expertise – from basic science to clinical trials – to leverage our breakthrough technology and launch the development of novel therapeutics.
Scalable large molecule Research and Development
Fast and comprehensive surfaceome discovery will thus accelerate the process of selecting novel molecular targets – for mono- as well as bi-specific antibodies – and expedite drug discovery.
Surfaceome discovery by protein community mapping
Our disruptive platform technology transforms our understanding of the surfaceome of cancer cells by identifying protein communities across the entire cell surface.
High confidence of protein surface localization
By knowing which proteins are truly present on the cell surface and participate within previously unrecognized protein communities, we can design highly specific large molecule therapeutics, thus boosting efficacy and reducing side effects.
